Pictet Asset Management’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,535
Closed -$56.5K 2072
2024
Q3
$56.5K Hold
14,535
﹤0.01% 1991
2024
Q2
$57K Hold
14,535
﹤0.01% 1938
2024
Q1
$60.9K Hold
14,535
﹤0.01% 1931
2023
Q4
$65.3K Hold
14,535
﹤0.01% 1918
2023
Q3
$45.2K Buy
+14,535
New +$58.4K ﹤0.01% 1914

Other funds holding MXCT

Pictet Asset Management's MXCT Position: Q4 2024 in Review

Pictet Asset Management sold out of MaxCyte (MXCT) in Q4 2024, closing a stake of 14,535 shares — an estimated $56.5K sold.

Pictet Asset Management first reported a position in MXCT in Q3 2023 and held it in 5 quarters. The position peaked at $65.3K in Q4 2023. 119 funds tracked by Wall St. Rank hold MXCT as of Q4 2024.

  • Pictet Asset Management reported no remaining MaxCyte position as of Q4 2024 after selling out during the quarter.
  • Pictet Asset Management sold 14,535 MaxCyte shares in Q4 2024, an estimated $56.5K.
  • Pictet Asset Management first reported a position in MaxCyte in Q3 2023 and held it in 5 quarters.
  • Pictet Asset Management's MaxCyte position peaked at $65.3K in Q4 2023.
  • 119 funds tracked by Wall St. Rank held MaxCyte as of Q4 2024.

Based on Pictet Asset Management's 13F filing for Q4 2024, filed 12 Feb 2025.